Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Vandana Singh

4606 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Integer Can Drive Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects

By Vandana Singh
May 15, 3:19 PM
Truist Securities initiates coverage on Integer. With a Buy rating and a $137 target, Integer is poised for significant gains driven by organic growth and strategic acquisitions.

ITGR

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Large Cap
  • News
  • Price Target

Boston Scientific’s Upside With Cardiology Devices Drives Momentum

By Vandana Singh
May 15, 3:02 PM
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum.

BSX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Large Cap
  • News
  • Price Target
  • Top Stories
  • Trading Ideas
  • Upgrades

Contact Lens Maker Alcon’s Has New Growth Avenues, Analyst Upgrades Stock

By Vandana Singh
May 15, 2:35 PM
Alcon's recent upgrades and promising opportunities, including the BELKIN Vision acquisition, expanding glaucoma treatment options, enhanced PanOptix IOL, and market advancements in China.

ALC

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

Takeda’s Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement

By Vandana Singh
May 15, 2:02 PM
Takeda's dengue vaccine, Qdenga, gains WHO prequalification, enabling UN agency procurement. Approved in multiple countries, Qdenga is recommended for children 6-16 in high dengue areas.

SNY

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Top Stories

No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms

By Vandana Singh
May 15, 11:59 AM
Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines Agency about limited supplies. The company addresses high demand and reassures the availability of all doses.

LLY

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

FDA Pushes Review Date For Ascendis Pharma’s Hormone Disorder Candidate By Three Months

By Vandana Singh
May 15, 11:57 AM
Ascendis Pharma announces FDA's extension of the review date for TransCon PTH for adults with hypoparathyroidism to August 14, 2024. TransCon PTH aims to address low calcium levels due to hypoparathyroidism.

ASND

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News
  • Top Stories

Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound

By Vandana Singh
May 15, 10:03 AM
Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease using Lilly branding. Corrective measures include compliance with federal law for tirzepatide products.

LLY

Read More
2 minute read
  • General
  • Health Care
  • News
  • Top Stories

Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High

By Vandana Singh
May 15, 8:37 AM
Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered samples out of 5.5 million in 2023. The rise in synthetic urine use and additives, along with varying state marijuana laws, poses challenges.

DGX

Read More
1 minute read
  • Contracts
  • Exclusives
  • General
  • Market-Moving Exclusives
  • News
  • Tech

EXCLUSIVE: Zapata AI Partners With India-Based Tech Mahindra To Transform Network And Customer Operations

By Vandana Singh
May 14, 4:13 PM
Zapata Computing partners with Tech Mahindra to revolutionize CSP solutions. Leveraging Zapata AI's quantum-based Generative AI, expect enhanced operational efficiency, proactive maintenance, and personalized customer interactions.

ZPTA

Read More
2 minute read
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Will Insulet’s Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market

By Vandana Singh
May 14, 2:44 PM
Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynamics and Insulet's future.

MDT

Posts pagination

Previous 1 … 18 19 20 … 461 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service